Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Santé Center for Healing's Expert Commentary on Stigma Surrounding Opioid Use Disorder

The current United States opioid overdose epidemic is a complex, multifaceted, public health emergency that urgently requires interventions. The economic burden of opioid use disorder is estimated to be over one billion dollars annually in the U.S. when accounting for healthcare and treatment, criminal justice, lost productivity, and value of life lost costs. A survey by the American Psychiatric Association indicated that 1/3 of those surveyed knew someone with an opioid use disorder (OUD). Yet the stigma surrounding OUD means that fewer than 20 percent of patients have access to treatment.


News provided by

Santé Center for Healing

Feb 03, 2022, 13:10 ET

Share this article

Share toX

Share this article

Share toX


ARGYLE, Texas, Feb. 3, 2022 /PRNewswire-PRWeb/ -- The current United States opioid overdose epidemic is a complex, multifaceted, public health emergency that urgently requires interventions. The economic burden of opioid use disorder is estimated to be over one billion dollars annually in the U.S. when accounting for healthcare and treatment, criminal justice, lost productivity, and value of life lost costs.(1)

One billion dollars annually in the U.S. when accounting for healthcare and treatment, criminal justice, lost productivity, and value of life lost costs.(1) This is rough 20K times than an average new car costs (6), 200 times more than having a 30s Super Bowl commercial (8), ten times more than a Mega Millions Drawing.(7)

Those who do not understand addiction, may blame the patients themselves for their lack of self-discipline. But opioid use is more than personal choices, as external factors out of someone’s direct control could also have an impact.

Post this

In addition to dollars, a comprehensive picture accounts for prevalence and finality of associated consequences. Over 70% of the 70,630 overdose deaths in 2019 involved an opioid. From 2018 to 2019, there were significant changes in opioid-involved death rates (2):

  • Opioid-involved death rates increased by over 6%.
  • Synthetic opioid-involved death rates increased by over 15%

A survey by the American Psychiatric Association indicated that 1/3 of those surveyed knew someone with an opioid use disorder (OUD). Yet the stigma surrounding OUD means that fewer than 20 percent of patients have access to treatment.(1)

Dr. Melissa Pennington, Santé's Medical Director commented on people's unwillingness to seek treatment for OUD. "The underlying cause of patients' opioid use disorder is very complicated, and stigma around their opioid use creates barriers for people to access care. Those who do not understand addiction, may blame the patients themselves for their lack of self-discipline. But opioid use is more than personal choices, as external factors out of someone's direct control could also have an impact. For example, a medically recommended use of opioids due to injuries could progress into an opioid addiction. As healthcare providers, we need to use person-centered language and deliver messages emphasizing evidence-based solutions, which will help patients returning to productive and fulfilling lives."

Stigmas cause challenges for those who are stigmatized, with reduced employment and educational opportunities, as well as marital and social problems. Many people have negative attitudes toward people with OUD and want to put distance between them.(3) A recent study in 2018 has shown that only 28 percent of Americans are willing to work with someone with OUD on their jobs, and only 16 percent of Americans would accept someone with OUD to marry into their families. Isolation, discrimination and prejudice are obstacles to social inclusion, which make people with OUD less likely to seek substance abuse treatment and maintain sobriety.(4)

The stigma on addiction extends to a stigma on treatment as well, as only 49% of Americans believe that there is an effective long-term treatment for opioid use disorder. However, FDA-approved medications for opioid use disorder, such as methadone, buprenorphine, and naltrexone, are effective in helping people overcome addiction, stay in recovery longer, and prevent relapse.(5) As half of Americans do not believe effective treatment exists, it is necessary to raise awareness, break stigmas to reduce treatment barriers and increase delivery of medications to people diagnosed with OUD, which the majority of Americans with opioid use disorder do not receive.(3) Therefore, on an individual level, we need to treat people who have been diagnosed with respect, avoid using stigmatizing language, develop a scientific understanding of the illness, and encourage our loved ones to seek help when needed. We should also advocate the collaboration between medical personnel, public health officials and community-based organizations so they can bring the awareness, resources, and expertise to address this complex and fast-moving epidemic.

For more on treating addiction at Santé, click here.

Sources
1. University, U. S. (n.d.). Reducing Stigma Towards Opioid Use Disorder Treatment. Retrieved October 31, 2021, from https://extension.usu.edu/heart/research/reducing-stigma-towards-opioid-use-disorder-treatment
2. Stigma Reduction. (2021, August 19). https://www.cdc.gov/stopoverdose/stigma/index.html
3. Guiding Principles for Addressing the Stigma on Opioid Addiction | Bloomberg American Health Initiative. (2019, December 5). Retrieved October 31, 2021, from https://americanhealth.jhu.edu/news/guiding-principles-addressing-stigma-opioid-addiction
4. Opioid Resources—Reducing Stigma Campaign. (n.d.). Retrieved October 31, 2021, from https://www.michigan.gov/opioids/0,9238,7-377-88148-512727--,00.html
5. Adams, Z. W., Taylor, B. G., Flanagan, E., Kwon, E., Johnson-Kwochka, A. V., Elkington, K. S., Becan, J. E., & Aalsma, M. C. (2021). Opioid Use Disorder Stigma, Discrimination, and Policy Attitudes in a National Sample of U.S. Young Adults. Journal of Adolescent Health, 69(2), 321–328. https://doi.org/10.1016/j.jadohealth.2020.12.142
6. Henry, J. (2021, October 31). Average New Car Price Tops $45,000, Used Car Price Over $25,000. Forbes Wheels. https://www.forbes.com/wheels/news/new-car-price-tops-45000/
7. Powerball and Mega Millions Lottery Results. (n.d.). Retrieved December 4, 2021, from https://www.usamega.com/
8. Sauter, M. B. (n.d.). Super Bowl commercials: Ads cost $5M+ for 30 seconds now. Here's how much they cost over the years. USA TODAY. Retrieved December 4, 2021, from https://www.usatoday.com/story/money/2021/02/06/super-bowl-commercials-cost-for-every-year-game-played/115437118/

Media Contact

Nicole Miller, Santé Center for Healing, 1 9404647222, [email protected]

SOURCE Santé Center for Healing

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.